Overview
Xuebing Li practices in Tianjin, China. Li is rated as an Advanced expert by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Their top areas of expertise are Lung Cancer, Familial Wilms Tumor 2, Non-Small Cell Lung Cancer (NSCLC), Adenoid Cystic Carcinoma, and Laryngectomy.
Their clinical research consists of co-authoring 77 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 17 articles in the study of Non-Small Cell Lung Cancer (NSCLC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Familial Wilms Tumor 2
- Lung CancerLi isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Adenoid Cystic Carcinoma
- Brain TumorLi isExperienced. Learn about Brain Tumor.
- Cerebral HypoxiaLi isExperienced. Learn about Cerebral Hypoxia.
- GliomaLi isExperienced. Learn about Glioma.
- Gliomatosis CerebriLi isExperienced. Learn about Gliomatosis Cerebri.
- Laryngeal CancerLi isExperienced. Learn about Laryngeal Cancer.